Drysol, Xerac AC (aluminum chloride topical) dosing, indications, interactions, adverse effects, and more

Sections

Sections aluminum chloride topical
Dosing & Uses
Adverse Effects
Warnings
Pregnancy
Pharmacology
Administration
Images
Patient Handout

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

topical solution

6.25% (Xerac AC)
15% (Hypercare)
20% (Drysol Extra Strength)

Hyperhidrosis

Indicated for severe, recalcitrant hyperhidrosis

Apply to affected area qHS; once excessive sweating decreases (typically after 2 or more treatments), decrease application to 1-2 times/week

May cover treated area with plastic wrap held in place by tight fitting t-shirt, mitten, or sock; do not hold in place with tape

Also see Topical Administration

Dosage Forms & Strengths

topical solution

6.25% (Xerac AC)
15% (Hypercare)
20% (Drysol Extra Strength)

Recalcitrant Hyperhidrosis

Infants and children: Safety and efficacy not established

Adolescents: Apply to affected area qDay at bedtime; once excessive sweating decreases (typically after 2 or more treatments), decrease application to 1-2 times/week

May cover treated area with plastic wrap held in place by tight fitting t-shirt, mitten, or sock; do not hold in place with tape

Also see Topical Administration

Frequency Not Defined

Irritation

Itching

Tingling

Contraindications

Hypersensitivity

Cautions

Do not apply to broken, irritated, or recently shaved skin

Discontinue use if irritation/sensitization occurs

External use only; avoid eyes

May harm certain metals or fabrics

Flammable: Do not use near open flame

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Unknown whether distributed in breast milk, caution advised

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Mechanism of Action

Astringent

Topical Administration

Apply to completely dry skin to avoid irritation

Do not apply to broken, irritated, or recently shaved skin

20% suitable for axillae, palms, and soles

BRAND	FORM.	UNIT PRICE	PILL IMAGE
Drysol Dab-O-Matic topical -	20 % solution
Drysol Dab-O-Matic topical -	20 % solution
Drysol topical -	20 % solution

Patient Handout

A Patient Handout is not currently available for this monograph.

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]